The new Lentiviral Reference Material (LVV-RM) article by the National Research Council Canada is ready! Click on the "Open Access Articles" tab below.
The new Lentiviral Reference Material (LVV-RM) article by the National Research Council Canada is ready! Click on the "Open Access Articles" tab below.
Skip to content
BioProcessing JournalBioProcessing Journal

Trends & Developments in BioProcess Technology / Since 2002

  • Home
  • Open Access Articles
  • Viral Reference Materials
  • twitter
  • linkedin
Home > Viral Reference Materials > The Ad5-RM Project > Adenovirus Reference Material Production

Adenovirus Reference Material Production

Bid Submission
  • Bid Submission, RFP 1.0, Cell Bank Donation
  • Award Letter – Introgen, RFP 5.0, ARM Production and Release Testing Donation
  • Bid Submission, Introgen – RFP 6.0, Vialing and Freezing Donation
Final Production Report and Appendices
  • Introgen – Final Production Report for ARM Vialed Products (4 lots total)
  • Magenta – C of A and Production Information, Master Cell Bank
  • BioReliance – Amended C of A, Master Cell Bank
  • Canji – C of A, Master Virus Bank
  • BioReliance – Working Cell Bank Viability
  • Trypsin C of A, and HyClone – FBS C of A
  • Introgen – C of A, ARM-Lot #001503
  • Introgen – C of A, ARM-Lot #001504
  • Introgen – C of A, ARM-Lot #001505
  • Introgen – C of A, ARM-Lot #001506

Primary Sidebar

KEYWORD SEARCH

Content

  • Open Access Articles

Author Information

  • Open Access
  • Submit a Manuscript
  • Author Guidelines
  • Editorial Advisory Board

Recently Published

  • Development of a Scalable Fed-Batch Bioreactor Process for High-Titer Production of Lentiviral Vector Using an Inducible HEK293 Producer Cell Line
  • Quality Risk Management (QRM): Part I – Identifying, Evaluating, and Mitigating Threat Risks to Biopharmaceutical Enterprises
  • Low-Pressure Liquid Chromatography Using the EcoPrime® With Enhanced Buffer In-Line Dilution
  • NGS-Based Viral Safety Testing for ATMPs: Mandatory or Just an Option?
  • Practical Considerations in Using an Equivalence Approach to Establish Lot Release Limits for Vector Dose
CONTACT INFO

8880 SW 27th Ave., Suite A84
Ocala, Florida 34476 USA
info@bioprocessingjournal.com
Phone: 757-447-7345

BioProcessing Journal

Trends & Developments in BioProcess Technology / Since 2002
© 2025 BioProcessing Journal. All rights reserved.

KEYWORD SEARCH